Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anthony K Blair Insider Profile
4 Followers
Anthony K Blair, COO at Zomedica Pharmaceuticals, holds 400.00K shares in Zomedica Pharmaceuticals (Ticker: ZOM). Most recently, Anthony K Blair Bought $150,000 shares of Zomedica Pharmaceuticals on Nov 13, 2024 for an estimated value of 18.00K.
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-14.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
COO
Roles that Anthony K Blair holds in companies
Most Profitable Insider Trade
The most profitable trade made by Anthony K Blair
Anthony K Blair's Trading History
List of latest transactions for each holding click on a transaction to see Anthony K Blair's performance on stock
You May Also Like
Anthony K Blair insider profile FAQ
What is the percentage of profitable transactions made by Anthony K Blair?
The percentage of profitable transactions made by Anthony K Blair is 0%.
What is the average return per transaction made by Anthony K Blair?
The average return per transaction made by Anthony K Blair is -14.90%.
What stocks does Anthony K Blair hold?
Anthony K Blair holds: ZOM stocks.
What was Anthony K Blair’s latest transaction?
Anthony K Blair latest transaction was an Informative Buy of $18.00K.
What was Anthony K Blair's most profitable transaction?
Anthony K Blair’s most profitable transaction was an Informative Buy of ZOM stock on August 20, 2024. The return on the trade was -11.50%.
What is Anthony K Blair's role in Zomedica Pharmaceuticals?
Anthony K Blair's role in Zomedica Pharmaceuticals is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.